GRI Bio, Inc. (GRI)
Nasdaq · Healthcare
$1.91−2.55%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $4.2M
- 52-week range
- $1.36 – $64.12
- 52-week change
- −96.50%
- EPS (trailing)
- −$14.71
Fiscal year to Dec 2025
- Net income
- −$12.0M
- Diluted EPS
- −$121.80
- Free cash flow
- −$10.2M
From the company’s annual report on SEC EDGAR.